Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Haobin Chen

Showing results (111-120 of 116) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 116 results.
Investigational New Drugs|July 1, 2009
Phase II study of darinaparsin in patients with advanced hepatocellular carcinomaJennifer Wu, Charles Henderson, Lynn Feun, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 7, 2024
Genome-Wide Analysis Identifies Nuclear Factor 1C as a Novel Transcription Factor and Potential Therapeutic Target in SCLCVivek Shukla, Haitao Wang, Lyuba Varticovski, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 14, 2020
UHRF1 Is a Novel Druggable Epigenetic Target in Malignant Pleural MesotheliomaEmily S Reardon, Vivek Shukla, Sichuan Xi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 19, 2017
Phase I Study of ATR Inhibitor M6620 in Combination With Topotecan in Patients With Advanced Solid TumorsAnish Thomas, Christophe E Redon, Linda Sciuto, et al.
Cell Reports. Medicine|June 3, 2020
Clonal Evolution and Heterogeneity of Osimertinib Acquired Resistance Mechanisms in EGFR Mutant Lung CancerNitin Roper, Anna-Leigh Brown, Jun S Wei, et al.
The Journal of Clinical Investigation|July 8, 2025
NOTCH1 reverses immune suppression in small cell lung cancer through reactivation of STINGYoo Sun Kim, Barzin Y Nabet, Briana N Cortez, et al.
Pageof 12

Showing results (111-120 of 116) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 116 results.
Investigational New Drugs|July 1, 2009
Phase II study of darinaparsin in patients with advanced hepatocellular carcinomaJennifer Wu, Charles Henderson, Lynn Feun, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 7, 2024
Genome-Wide Analysis Identifies Nuclear Factor 1C as a Novel Transcription Factor and Potential Therapeutic Target in SCLCVivek Shukla, Haitao Wang, Lyuba Varticovski, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 14, 2020
UHRF1 Is a Novel Druggable Epigenetic Target in Malignant Pleural MesotheliomaEmily S Reardon, Vivek Shukla, Sichuan Xi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 19, 2017
Phase I Study of ATR Inhibitor M6620 in Combination With Topotecan in Patients With Advanced Solid TumorsAnish Thomas, Christophe E Redon, Linda Sciuto, et al.
Cell Reports. Medicine|June 3, 2020
Clonal Evolution and Heterogeneity of Osimertinib Acquired Resistance Mechanisms in EGFR Mutant Lung CancerNitin Roper, Anna-Leigh Brown, Jun S Wei, et al.
The Journal of Clinical Investigation|July 8, 2025
NOTCH1 reverses immune suppression in small cell lung cancer through reactivation of STINGYoo Sun Kim, Barzin Y Nabet, Briana N Cortez, et al.
Pageof 12